|
Allergan Plc's Revenue per Employee
Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales
With a revenue increase of 0.2% in the first quarter 2020, year on year to cumulative value of $16,096 million, Allergan Plc's revenue per employee grew on a trailing twelve months basis to $ 1,532,971, this is below the company average. Within the Healthcare sector Employees of 4 other companies have achieved higher revenue per employee. While Allergan Plc's total ranking has deteriorated compared to the previous quarter from 69 to 141. Allergan Plc has 10,500 employees.
What is Sales per Employee Ratio?
Select the Comparisons :
|
|
Select the Ratio:
|
|
AGN Revenue per Employee |
(Mar 31 2020) I. Quarter |
(Dec 31 2019) IV. Quarter |
(Sep 30 2019) III. Quarter |
(Jun 30 2019) II. Quarter |
(Mar 31 2019) I. Quarter |
Y / Y Revenue Change |
0.2 % |
6.65 % |
3.56 % |
-0.83 % |
-2.04 % |
Sales per Employee
(TTM) $ |
1,532,971 |
1,532,276 |
1,506,438 |
1,493,171 |
1,496,419 |
AGN's Total
Ranking |
# 141 |
# 69 |
# 172 |
# 222 |
# 218 |
Seq. Revenue Change |
-17.16 % |
7.41 % |
-0.96 % |
13.71 % |
-11.83 % |
Revenue per Employee Statistics |
High |
Average |
Low |
$ 1,796,848 |
$ 772,029 |
$ 218,048 |
(March 31, 2016) |
|
(Sep. 30, 2005) |
Date modified: -0001-11-30T00:00:00+00:00
Companies with similar Revenue per Employee for 12 months ending Mar 31 2020, within Healthcare Sector | Revenue per Employee | Revenue 12 months ending Mar 31 2020 | Number of Employees Mar 31 2020 | Exelixis Inc | 1,730,040.64 | $ 979.203 Million | 566 | Gilead Sciences Inc | 1,577,500.00 | $ 22,716.000 Million | 14,400 | Enanta Pharmaceuticals Inc | 1,570,258.93 | $ 175.869 Million | 112 | Allergan plc | 1,532,971.43 | $ 16,096.200 Million | 10,500 | Biogen Inc | 1,500,770.03 | $ 14,422.400 Million | 9,610 | Alexion Pharmaceuticals Inc | 1,380,114.67 | $ 5,295.500 Million | 3,837 | Vertex Pharmaceuticals Inc | 1,235,767.44 | $ 4,819.493 Million | 3,900 | Cryoport inc | 1,195,582.68 | $ 37.063 Million | 31 | Incyte Corporation | 1,064,665.23 | $ 2,229.409 Million | 2,094 | Amgen Inc | 990,330.58 | $ 23,966.000 Million | 24,200 | Bristol myers Squibb Company | 962,919.25 | $ 31,006.000 Million | 32,200 | Patterson Companies Inc | 784,287.29 | $ 5,490.011 Million | 7,000 | Regeneron Pharmaceuticals Inc | 769,656.64 | $ 7,979.800 Million | 10,368 |
|